Abstract:As normal tissues contain normal tissue stem cells (NSCs), tumors are thought to contain tumor stem cells (TSCs) which perform self-renewal and generate their progenies. TSC can be a therapeutic target; however, cancer therapies targeting TSCs are limited, because most of the TSC markers are shared by NSCs. Therefore, it is important to identify TSC-specific markers. Previously, we reported that doublecortin-like kinase 1 (Dclk1)-positive epithelial cells do not produce any progenies in the normal small intestine but supply progeny tumor cells in the tumors of Apc mice. Selective ablation of Dclk1-positive TSCs collapses the intestinal tumors of Apc mice. Therefore, Dclk1 appears to be a specific marker of TSCs in the mouse intestinal tumors. In the present study, we performed microarray analysis in order to investigate the characteristics of Dclk1-positive TSCs in the tumors of Apc mice. Dclk1-positive tumor cells had higher expression levels of cyclooxygenase 1 (Cox1), leukotriene C4 synthase (Ltc4s), and arachidonate 5-lipoxygenase activating protein (Alox5ap) than Dclk1-negative cells in the tumors of Apc mice, suggesting that Dclk1positive cells in the tumors of Apc mice had higher expression levels of the genes which were related to prostaglandin and leukotriene metabolism. As well, microarray analysis revealed that gustducin alpha and gamma subunits, transient receptor potential cation channel, subfamily M, member 5 (TRPM5), and phospholipase C beta 2 were more highly expressed in Dclk1-positive tumor cells. Thus, Dclk1-positive tumor cells seemed to possess the characteristic of Tuft cells. Furthermore, Dclk1-positive tumor cells had higher expression level of Ras-related C3 botulinum toxin substrate 2 (Rac2) than Dclk1-negative tumor cells in Apc mouse intestine. In order to elucidate the role of Rac2 in Dclk1-positive TSCs, we generated tumor spheroids from Apc mouse tumors, and administrated EHT1864, Rac inhibitor to the spheroids. Following 5-day treatment with EHT1864, the growth of the tumor spheroids was significantly suppressed. Importantly, on day1, EHT1864 treatment significantly reduced the proportion of Dclk1-positive cells in the tumor spheroids. These results suggested that Rac2 played some roles for the maintenance of the intestinal tumor spheroids. In conclusion, this study may provide new insights into the maintenance mechanisms of Dclk1-positive TSC in the intestinal tumors, and give us hints to develop novel therapeutic strategies targeting TSCs against colorectal cancers.

Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways.

Inhibitor Of Dna Binding1 (Id1) Mediates Stemness Of Colorectal Cancer Cells Through The Id1-C-Myc-Plac8 Axis Via The Wnt/Beta-Catenin And Shh Signaling Pathways

ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer

Su2003 Nrip2, a Novel Regulator of the Non-Canonical Wnt Pathway, Promotes the Self-Renewal of Colorectal Cancer Initiating Cells

STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 (ID1) to Promote Colon Cancer Progression

Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy

Id1 Deficiency Protects against Tumor Formation in Apc(Min/+) Mice but Not in a Mouse Model of Colitis-Associated Colon Cancer

Id4 Suppresses the Growth and Invasion of Colorectal Cancer HCT116 Cells through CK18-Related Inhibition of AKT and EMT Signaling

A Novel Role of Id-1 in Regulation of Epithelial-to-mesenchymal Transition in Bladder Cancer.

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.

Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1

Sirna-Mediated Knockdown of ID1 Disrupts Nanog- and Oct-4-mediated Cancer Stem Cell-Likeness and Resistance to Chemotherapy in Gastric Cancer Cells.

Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer

High Levels of SIRT1 Expression Enhance Tumorigenesis and Associate with a Poor Prognosis of Colorectal Carcinoma Patients

Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal Cancer

JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level

The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT Pathway

ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human

Inhibitor of DNA Binding 2 Knockdown Inhibits the Growth and Liver Metastasis of Colorectal Cancer.

Identifying the E2F3-MEX3A-KLF4 Signaling Axis That Sustains Cancer Cells in Undifferentiated and Proliferative State

ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma.